ghk-cu/bpc157/tb500 Glow (BPC-157/TB-500/GHK-Cu) — IVs in the Keys Glow Stack — BPC-157, TB-500

The FDA announced the action on April 15, 2026 (Federal Register notice April 16), and the peptides come off the Category 2 list effective April 23, 2026

If youre curious about trying a GHK-Cu serum or other copper peptide skin care products: Look for formulations containing copper peptides (around 0.11% is typical in cosmetic products as higher percentages are less commonly standardised)

Selected Data 1) Previous research has determined the ability of AngIV analogs such as Dihexa, to increase cerebral blood flow, elicit neuroprotective effects, and promote long term potentiation, learning, and memory consolidation

Research-grade peptides, widely available online, are not held to the stringent purity and safety standards of pharmaceutical-grade materials and are intended for experimental use only